Mark David Hackett
What matters now
- 2020since
Manager at Solas Bioventures Management, LLC since 1 Mar 2020.
Tenure says how settled this partner is at the firm.
Roles
- Solas Bioventures Management, LLC ManagerMar 1, 2020 to present · “Schedule A: Hackett, Mark, David, MANAGER, since 03/2020, ownership B, control person Y”Fact Form ADV
Investments attributed to this person
| Company | Round | Investor | Attribution | Date | Source |
|---|---|---|---|---|---|
| CardioNXT | Form D equity offering · $3.0M | Solas Bioventures Management, LLC | strongly supported · board | Mar 27, 2019 | Inference sec.gov |
| Glenveigh Pharmaceuticals, LLC | Form D equity offering · $1.1M | Solas Bioventures Management, LLC | strongly supported · board | May 14, 2012 | Inference sec.gov |
| Glenveigh Pharmaceuticals, LLC | Form D equity offering · $250,000 | Solas Bioventures Management, LLC | strongly supported · board | Nov 29, 2011 | Inference sec.gov |
Board seats and vehicles
- CardioNXT board seat on a deal Mar 27, 2019 Inference
- Glenveigh Pharmaceuticals, LLC board seat on a deal May 14, 2012 Inference
Timeline
- Mar 1, 2020Joined Solas Bioventures Management, LLC as Manager
- Mar 27, 2019
- May 14, 2012Form D equity offering in Glenveigh Pharmaceuticals, LLC (Solas Bioventures Management, LLC)
- Nov 29, 2011Form D equity offering in Glenveigh Pharmaceuticals, LLC (Solas Bioventures Management, LLC)